News

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry

Metaphore Biotechnologies 05.16.2023

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™ (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI

Seres Therapeutics 04.26.2023

YourBio Health's TAP® Micro Select Secures FDA 510(k) Medical Device Clearance for Producing Capillary Whole Blood Samples

YourBio Health 04.24.2023

Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That are Programed to Act Only Where Needed

Ampersand Biomedicines 03.07.2023

Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner

01.31.2023

Flagship Pioneering Announces Appointment of Pablo J. Cagnoni, M.D., as Executive Partner

11.02.2022

Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review

Seres Therapeutics 10.26.2022

Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats

Apriori Bio 07.11.2022

Flagship Pioneering Unveils ProFound™ Therapeutics to Illuminate an Expanded Universe of Human Proteins with the Potential to Enable a Multitude of New Medicines

ProFound™ Therapeutics 05.26.2022

Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock

Evelo Biosciences 05.25.2022

Loading